Atara Biotherapeutics (ATRA) Cash from Investing Activities Growth (3y) (2017 - 2025)
Atara Biotherapeutics (ATRA) Cash from Investing Activities Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,824.80 Bn | 1,824.74 Bn | - | - |
| 2 | Akari Therapeutics | 955.99 Bn | 955.99 Bn | - | - |
| 3 | BeOne Medicines | 473.90 Bn | 469.11 Bn | 1.35 Bn | -29.84% |
| 4 | Vertex Pharmaceuticals | 123.79 Bn | 116.54 Bn | 2.59 Bn | 38.24% |
| 5 | Regeneron Pharmaceuticals | 71.64 Bn | 62.88 Bn | 3.31 Bn | -22.09% |
| 6 | Belite Bio | 62.78 Bn | 62.78 Bn | - | - |
| 7 | Argenx Se | 55.45 Bn | 50.27 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | 30.54% |
| 9 | Revolution Medicines | 37.16 Bn | 37.16 Bn | - | - |
| 10 | Atara Biotherapeutics | 109.27 Mn | 100.91 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.18% |
| Sep 30, 2025 | -26.84% |
| Jun 30, 2025 | -29.25% |
| Mar 31, 2025 | -34.14% |
| Dec 31, 2024 | 28.84% |
| Sep 30, 2024 | -151.76% |
| Jun 30, 2024 | -39.12% |
| Mar 31, 2024 | 2.92% |
| Dec 31, 2023 | 31.42% |
| Sep 30, 2023 | 110.41% |
| Jun 30, 2023 | 33.51% |
| Mar 31, 2023 | -29.15% |
| Dec 31, 2022 | 256.86% |
| Sep 30, 2022 | 44.55% |
| Jun 30, 2022 | -14.12% |
| Mar 31, 2022 | -3.78% |
| Dec 31, 2021 | -36.23% |
| Sep 30, 2021 | -52.91% |
| Jun 30, 2021 | 117.05% |
| Mar 31, 2021 | 27.12% |